Stanley Pestotnik, MS, RPh.
Pestotnik will lead Health Catalyst’s efforts to reduce patient harm. He will drive innovation to deliver solutions that go beyond identifying and measuring harm, to alerting clinicians early and even predicting harm events before they happen.
Pestotnik is a clinical pharmacist and medical informaticist with over 25 years’ experience in health IT focused on patient safety and infectious diseases. He is the founding CEO of TheraDoc, Inc., a health care informatics company specializing in real-time clinical surveillance and decision support technology. TheraDoc was acquired by Hospira in December 2009. Prior to TheraDoc he was the Director of LDS Hospital Drug Surveillance and Safety Program for Intermountain Health Care’s Infectious Diseases Informatics Group.
